4.6 Article

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin

Ina Bergheim et al.

JOURNAL OF HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study

Shira Zelber-Sagil et al.

JOURNAL OF HEPATOLOGY (2007)

Article Gastroenterology & Hepatology

Increased intestinal permeability in obese mice:: new evidence in the pathogenesis of nonalcoholic steatohepatitis

Paola Brun et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)

Article Nutrition & Dietetics

Dietary habits and nutrient intake in non-alcoholic steatohepatitis

Kumiko Toshimitsu et al.

NUTRITION (2007)

Article Pharmacology & Pharmacy

Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis

I Bergheim et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Article Gastroenterology & Hepatology

Increased orocecal transit time in patients with nonalcoholic fatty liver disease

A Soza et al.

DIGESTIVE DISEASES AND SCIENCES (2005)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Article Gastroenterology & Hepatology

Dietary composition and nonalcoholic fatty liver disease

S Solga et al.

DIGESTIVE DISEASES AND SCIENCES (2004)

Article Hematology

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

MC Alessi et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)

Article Multidisciplinary Sciences

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

XL Du et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)